Drug Type Small molecule drug |
Synonyms BUPIVACAINE HYDROCHLORIDE/EPINEPHRINE, Marcaine Hydrochloride W/Epinephrine |
Mechanism ADRA1 agonists(Adrenergic receptor alpha-1 agonists), SCNA blockers(Sodium channel alpha subunit blockers), β-adrenoceptors agonists(Beta adrenergic receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (03 Oct 1972), |
Regulation- |
Molecular FormulaC18H31ClN2O2 |
InChIKeyHUCIWBPMHXGLFM-UHFFFAOYSA-N |
CAS Registry73360-54-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Analgesia | AU | 31 Jul 1991 | |
Anesthesia | US | 03 Oct 1972 |
Not Applicable | 127 | Placebo (PLACEBO) | chppkjyioc(rlifjqpfql) = ncarxjtqsz cajuchwvmz (eynjtzrvdy, ewvrznvhie - zmjtubyhbd) View more | - | 27 Mar 2018 | ||
(US TAP Bupivacaine/Epinephrine) | chppkjyioc(rlifjqpfql) = grjyejxjsv cajuchwvmz (eynjtzrvdy, teyjycteml - qozzdbvanm) View more | ||||||
Phase 4 | 50 | Holter ECG monitor (General Anesthesia (G)) | wwbarujbtg(qvohdbzevj): P-Value = 0.3861; P-Value = 0.2591 View more | - | 25 Apr 2017 | ||
Holter ECG monitor+Bupivacaine-fentanyl (Combined General/Epidural (G/E)) |